Meet the Research Team
Dr. Rodolfo Bordoni
Rodolfo Bordoni, MD is Director of Clinical Research and is the Principal Investigator of all clinical trials conducted at GCS. Dr. Bordoni serves as the Chairman of the Research and Therapeutics Committee and is co-principal investigator of the annual Lung Cancer Symposium. He is a member of the Board of Directors and Co-Chair of the Georgia Lung Cancer Working Group of the Georgia Center for Oncology Research and Education.
“Doing research, to me, is contributing to society as a whole, and participating in research makes me feel like I am contributing to move the whole forward. I enjoy being a part of the force and energy that comes from research and innovation.”
Dr. Simbo Aduloju
Simbo Aduloju, MD works with the research program from the Stemmer office in Decatur. He is a member of the American College of Physicians and has been awarded the Zemansky Introduction to Physics Prize, the Minority Access to Research Career Scholarship, and the Edward Stein Full Tuition Scholarship Award.
“I’m involved in GCS’s research program because it creates treatment opportunities to community oncology patients and allows them to experience a broad range of treatment options in this era of targeted therapy.”
Dr. Aaron Alizadeh
Aaron Alizadeh, MD is the lead sub-investigator at our Stemmer office. During Fellowship, Dr. Alizadeh worked in Dr. Mamoru Shoji's lab evaluating drug conjugation with tissue factor expressing tumor cells. Before relocating to Atlanta, he worked as a faculty member for the William Beaumont Hospital Medical Oncology Fellowship Program and participated in clinical trial work with Beaumont's NCI designated Community Clinical Oncology Program. Dr. Alizadeh is a member of the American Society of Clinical Oncology and the American Society of Hematology.
“As an oncologist, I believe I have a responsibility to contribute towards research. So much of today’s treatment benefits that are offered to our patients stand on the shoulders of prior research endeavors. Georgia Cancer Specialists consistently offers our patients cutting-edge clinical trials. These trials ultimately serve our patients by offering them new treatment opportunities which they otherwise might not have access to.”
Dr. Ranjana Bhargava, MD
Dr. Ranjana Bhargava, MD is the lead sub-investigator at our Athens office. Dr. Bhargava completed a fellowship in oncology and hematology at the University of Maryland Marlene and Stewart Greenebaum Cancer Center in Baltimore, MD. She has presented at regional and national meetings and most notably presented an abstract at the 2012 ASCO conference titled the “Association between Vitamin D Deficiency and Breast Cancer Histology: A Retrospective Database Review”.
Dr. Gina D’Amato
Dr. Gina D'Amato, MD is the lead sub-investigator at our Northside office. Before joining GCS, Dr. D’Amato served as the Director of Sarcoma Medical Oncology at the Winship Cancer Institute at Emory University. Dr. D’Amato completed her fellowship in oncology and hematology at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL where she also served as a Sarcoma Medical Oncologist and was involved in both translational and clinical trial research. Her job as the global medical director for TRM Oncology, allowed her to attend the majority of international oncology conferences while keeping her up to date on the latest research findings on sarcomas and other cancers.
“Being involved in clinical research is another way to provide hope to my cancer patients,” said Dr. D’Amato. “The best way to advance medicine and establish better treatment options is through cancer research which culminates in clinical trials. By participating in a clinical trial, not only do patients have the opportunity for a promising new treatment, but they can help future patients.”
Dr. Nishan Fernando, MD
Dr. Nishan Fernando, MD is the lead sub-investigator at our Cumming office. His certifications for the American Board of Internal Medicine are in both Medical Oncology and Internal Medicine. Dr. Fernando is a frequent and well-known speaker in the medical oncology community and has published numerous papers-particularly concerning colorectal cancer in publications like the Journal of Clinical Oncology.
Dr. Pradeep Jolly, MD
Dr. Pradeep Jolly, MD is the lead sub-investigator at our Center Pointe office. For the American Cancer Society he sits on the Board of Directors and am also a part of the American Society of Clinical Oncology, Medical Association of Georgia (MAG), and take part in many other professional societies and associations. While achieving his Research Fellowship at the Emory University School of Medicine he worked diligently in the Leukemia Laboratory. Dr. Jolly is currently board certified with the American Board of Internal Medicine in medical oncology, hematology, and internal medicine.
Dr. Cheryl Jones
Cheryl Jones, MD is the lead sub-investigator at our Macon office. She is committed to delivering clinical research opportunities to patients in their communities. She serves as the GCS site principal investigator in Macon and is an active participant in the GCS Research and Therapeutics Committee. Dr. Jones also served as president of the Bibb County Medical Society in 2004. She has served on the Board of Directors for the Medical Association of Georgia, the Middle Georgia Educational Foundation, the Middle Georgia Affiliate of the Susan G. Komen Foundation, the American Cancer Society in Dougherty and Bibb Counties, and the State of Georgia.
“It is important to offer these latest advances and opportunities to our patients. Not only do our patients and their families benefit from the availability of the cutting-edge research we offer at GCS, but everyone whose life may one day be touched by a cancer diagnosis benefits, too.”
Dr. Jorge P. Leguizamo, MD
Dr. Jorge Leguizamo, MD is the lead sub-investigator at our Cumming office. Before joining Georgia Cancer Specialists, he served as a Clinical Trials Coordinator at Jordan Hospital Cancer Center in Plymouth, MA, a Principal Investigator and Medical Monitor at the Naval Medical Center Portsmouth IN Portsmouth, VA, and a Senior Research Fellow at the National Cancer Institute in Bethesda, MD.
Dr. Richard Loyd
Dr. Richard Loyd, DO is the lead sub-investigator at our Athens office. Dr. Loyd is a member of the American Society of Clinical Oncology and actively serves on the board of directors for the Georgia Osteopathic Medical Association (GOMA). He is also on the adjunct faculty of the Mercer University School of Pharmacy.
“My parents taught me at an early age the virtue of service. Medicine provides the greatest opportunity to serve mankind. I have found that the richest blessings of life are recognized as we serve our fellow men.”
Dr. Premila Malhotra, MD
Premila Malhotra, MD is the lead sub-investigator at our Macon-Coliseum office. Dr. Malhotra was the Chief Fellow in Hematology/Oncology at Tulane University Medical Center in New Orleans, Louisiana. She is currently a member of the American Society of Clinical Oncology and the American Society of Hematology.
“I am passionate about cancer research because the advances made in cancer research over the last decade have fundamentally changed how people look at cancer. It is not looked upon a death sentence any more. The emerging scientific landscape offers the promise of significant advances for current and future cancer patients.”
Dr. Ursula Reusch, MD
Dr. is the lead sub-investigator at our Macon-Coliseum office. Dr. Reusch completed her Residency and Fellowship at Brown Medical School in Rhode Island. She was involved in preclinical research in developing new immunologic cancer treatments. She has participated in clinical research trials in practice in Rhode Island.
“It is absolutely amazing how far we have come in the past 40 years – from ‘cancer is universally a death sentence’ to now we are curing more and more cancers and increasing quantity and quality of life. This only happened due to the dedication of researchers both in the lab and in the treatment center. The directions in the past 1-2 decades towards biological and immunological treatments that are better tolerated and hold so much more promise is exciting. We are just scratching the surface of the possibilities. Let’s work on getting more and more cancers on the ‘CURED!’ list.”
Dr. Priya Rudolph, MD
Dr. Priya Rudolph, M.D., PhD is the lead sub-investigator at our Athens office. She completed her residency and fellowship at Yale University School of Medicine in New Haven, Conn. Dr. Rudolph currently sits on the Advisory Board for the Cancer Support Community in Cincinnati, Ohio and is a Moderator on the Tumor Board at Mercy Western Hills Hospital in Cincinnati, Ohio.
“I encourage my patients to participate in clinical trials because they are key to advancing medical care. GCS offers many clinical trial options for our patients which are helpful in determining strategies and treatments that may be more effective than currently available treatment options.”
Dr. Jayanthi Srinivasiah, MD
Dr. Jayanthi Srinivasiah (Dr. Jay), MD is the lead sub-investigator at our Stemmer office. She is very active in recruiting patients for participation in clinical trials, and emphasizes care of the whole patient throughout cancer treatment. Dr. Jay received the NCI clinical trials award and is passionate about finding new cures through cancer research.
Dr. Gena Volas-Redd, MD
Dr. Gena Volas-Redd, MD is the lead sub-investigator at our Kennestone office. Notable speaking obligations she has been invited to include the International Association for the Study of Lung Cancer in Barcelona, Spain and has presented countless abstracts nationally. Dr. Volas-Redd currently works with the Atlanta Region CCOP Clinical Trial Network with UAB on a weekly basis.